End points for new agents in induction chemotherapy for locally advanced head and neck cancers.
about
Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial.Effect of induction chemotherapy on speech and swallowing function in patients with oral tongue cancerSerum signature of hypoxia-regulated factors is associated with progression after induction therapy in head and neck squamous cell cancer.Treatment outcome of maxillary sinus cancer.Immunomodulated anterior chemotherapy followed by concurrent chemoradiotherapy in locally advanced tongue cancer: An Institutional experience.Laryngeal cancer: United Kingdom National Multidisciplinary guidelines.Future chemotherapy and radiotherapy options in head and neck cancer.Randomized scheduling feasibility study of S-1 for adjuvant chemotherapy in advanced head and neck cancer.Induction chemotherapy in patients with resectable head and neck squamous cell carcinoma: a meta-analysis.Docetaxel in the management of patients with head and neck squamous cell carcinoma.Feasibility analysis of the parametric response map as an early predictor of treatment efficacy in head and neck cancer.Head and neck cancer: response to p53-based therapeutics.Promising new molecular targeted therapies in head and neck cancer.Cisplatin, cetuximab, and radiation in locally advanced head and neck squamous cell cancer: a retrospective review.A mouse model for oral squamous cell carcinoma.Using low-dose radiation to potentiate the effect of induction chemotherapy in head and neck cancer: Results of a prospective phase 2 trial.Accelerated radiotherapy for advanced laryngeal cancer.Induction chemotherapy with S-1 plus cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck.Efficacy and survival rate of intensity-modulated radiotherapy combined with chemotherapy for elderly patients with locally advanced oropharyngeal cancer.Advances in Collaborative Practice for Patients With Head and Neck Cancers.TPF induction chemotherapy increases PD-L1 expression in tumour cells and immune cells in head and neck squamous cell carcinoma.
P2860
Q33561959-1332F330-355D-46FD-87EF-B535D0A88537Q33836133-B9061426-565A-436A-BE26-3BE7F635FDD2Q34032602-8937B57F-7923-4800-8CA2-D41757E725ECQ34364653-107AB7AD-698C-4444-B165-4E8718845E57Q35188885-BB94B598-01FE-452C-A78E-4138BC0D3AADQ36191405-849FB62B-902A-4C38-A0FB-41BABCB660C8Q36407462-DC40ADBE-2E7B-4E01-8D0B-689938E40B6CQ36615451-1BBAF422-33FC-4B67-B9D5-18B7291418EAQ36697794-86D7324B-10A6-4104-9DA0-51589AA9282BQ37202758-59235C4C-4066-407B-9D69-9B652FB87CCCQ37567544-0612D092-E2D5-4FCC-96BA-80B8B5E52987Q37707255-E92715A7-D98F-42D0-BA3C-81BCF1D49D98Q38084617-EE3AF972-5866-4532-8BA7-DAEB32C1D08EQ38335130-1EEC8C70-4FC6-43FD-82AC-4CD5015AC206Q39954977-96C3E345-69AC-4E9C-9F93-F1D96B82D921Q40121235-380DA3D6-B97A-4BB5-9A18-33B1D0BEA2EFQ46665712-35364A5B-A198-4A5C-AB14-C4EE1C8A96F0Q46875032-01921412-B5ED-4309-89DD-B405064B59D5Q55095894-44DD8E84-BAF5-4DF1-A7B9-CF6508531862Q55436332-A4D7B50F-A965-41A9-9F8D-D13FDCCC96DCQ55644910-93C18CC7-9B52-47E4-B50F-DDEB489E3EEB
P2860
End points for new agents in induction chemotherapy for locally advanced head and neck cancers.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
End points for new agents in i ...... dvanced head and neck cancers.
@ast
End points for new agents in i ...... dvanced head and neck cancers.
@en
End points for new agents in i ...... dvanced head and neck cancers.
@nl
type
label
End points for new agents in i ...... dvanced head and neck cancers.
@ast
End points for new agents in i ...... dvanced head and neck cancers.
@en
End points for new agents in i ...... dvanced head and neck cancers.
@nl
prefLabel
End points for new agents in i ...... dvanced head and neck cancers.
@ast
End points for new agents in i ...... dvanced head and neck cancers.
@en
End points for new agents in i ...... dvanced head and neck cancers.
@nl
P2093
P2860
P356
P1433
P1476
End points for new agents in i ...... advanced head and neck cancers
@en
P2093
P2860
P304
P356
10.1093/ANNONC/MDF172
P577
2002-07-01T00:00:00Z